Conference Theme and Plenary Speakers Announced for ISPOR Asia Pacific 2018

Published Jun 25, 2018

Region’s Leading Health Economics and Outcomes Research Conference to Focus on Informing Policy and Strengthening Healthcare Systems

Lawrenceville, NJ, USA—June 25, 2018—ISPOR, the professional society for health economics and outcomes research, announced the theme and plenary sessions for its ISPOR Asia Pacific 2018 conference. The conference is scheduled for 8-11 September 2018 in Tokyo, Japan. ISPOR Asia Pacific 2018 is the leading Asia Pacific conference for health economics and outcomes research (HEOR) and will focus on the theme, “Moving Into Action: Informing Policy and Strengthening Healthcare Systems in Asia Pacific.” The first plenary session, “Transforming Healthcare and Leveraging Digital Health for Better Health in Asia Pacific,” is scheduled for Sunday, 9 September 2018. This session will explore the current benefits and the future potential of digital health in the region. Speakers will include:
  • Moderator: Erwin Loh, MBBS, MBA, MHSM, PhD, Monash Health, Melbourne, Australia
  • Speaker: Gabe Rijpma, Microsoft Asia, Auckland, New Zealand
  • Speaker: Polawat Witoolkollachit, MD, Ministry of Public Health, Bangkok, Thailand
  • Speaker: Jilan Liu, MD, MHA, Joint Commission International, Healthcare Information and Management Systems Society (HIMSS Greater China), Seattle, WA, USA
  • Speaker: Lou Huei-Xin, PharmD, MSc, Integrated Health Information Systems Pte Ltd and Ministry of Health, Singapore
The second plenary session, “Real-World Evidence in Asia Pacific: Are We Ready? Is It Helpful for Decision Makers?,” is scheduled for Monday, 10 September 2018. In this session, speakers from various sectors will share their perspectives and insights on the use of real-world evidence and address barriers impeding its utilization. Speakers will include:
  • Moderator: Bart Barefoot, GlaxoSmithKline, London, UK
  • Speaker: K. Arnold Chan, MD, ScD, National Taiwan University, Taipei, Taiwan
  • Speaker: Xin Sun, PhD, Sichuan University, Chengdu, China
  • Speaker: Manabu Akazawa, PhD, MPH, Meiji Pharmaceutical University, Tokyo, Japan
The third plenary session, “Risk-Sharing Agreements: Country Experiences, Challenges, and Lessons Learned,” is scheduled for Tuesday, 11 September 2018. In this session, panelists will address the issues and challenges in implementing risk-sharing agreements.
  • Moderator: Joerg Mahlich, Janssen, Neuss, Germany
  • Speaker: Elizabeth de Somer, Medicines Australia, Canberra, Australia
  • Speaker: Youngjin Song, Ministry of Health and Welfare, Seoul, South Korea
  • Speaker: Gergana Zlateva, PhD, Pfizer Inc, New York, NY, USA
ISPOR is recognized globally as the leading professional society for health economics and outcomes research (HEOR) and its role in improving healthcare decisions. ISPOR Asia Pacific 2018 draws approximately 1500 healthcare stakeholders with an interest in HEOR, including policy makers, global thought leaders, researchers and academicians, public and private payers, decision makers, and patient representatives. The conference also features the Society’s renowned Essential HEOR Education curriculum of short courses on 8 September 2018. Additionally, a wide variety of breakout sessions will be featured, including issue panels, workshops, forums, educational symposia, podium presentations, and poster presentations.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×